ARCHIVES

Clinical Trials Approved In August 2002 By NCI

This article is from The Cancer Letter archive.

Vol. 25 No. 9 | September 27, 2002

Download PDF Visit The Full Archive

Related Articles

Turnover In Immunology Contracts To Free Up Substantial Sums, Possible New RFPs Listed

October 8, 1976

ACCC Seeking Line Item, $21 Million for CCPs; Results Of Evaluation Released

June 5, 1987

FDA Approves Taxotere And Gemzar; Sends Approvable Letter For Etopophos

May 24, 1996

NCI Director To Decide Fate Of P-4 After NCAB Meeting In June.

April 20, 2007

DCT Board Says RDOG Concept Too Expensive; Discusses Grant Funding

July 24, 1992

OMB Restriction On Reprogramming Threatens Grants Of Three Centers, Possible Restorations

June 6, 1986